Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden, Emphasis in the literature is on physical symptom recognition and management, in contrast to the patient's perspective of the effects of heart failure on his/her daily life.Methods: This review summarizes and integrates research findings on anxiety and depression and translates these findings to clinical practice.Results: Depression and anxiety are prevalent among patients with heart failure, and require assessment and intervention. Short-term nonpharmacologic approaches, in conjunction with drug therapy, hold promise in for successful management of patients who are depressed and or anxious.
Conclusions:Carefully designed clinical trials that are tailored to individual needs, yet are embedded within a systemic framework, are needed to inform clinicians regarding optimal practices for the treatment of patients with heart failure who suffer from depression and/or anxiety.Key words: heart failure, depression, anxiety, cognitive behavioral therapy 4 Although HF has been described as "a new epidemic" with more than five million Americans identified and 500,000 newly diagnosed with HF annually, it has also been identified as a "last frontier" of behavioral cardiology.Psychosocial issues, particularly depression and anxiety, in patients with HF have been